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THE peripheral lymphocytes from
patients with malignant disease were
reported by Field and Caspary (1970)
to be sensitive to encephalitogenic factor
(EF) which is extracted from human
brain. The incubation of these sensitive
lymphocytes with EF was found to
produce a soluble factor (MSF) which
reduces normal guinea-pig macrophage
electrophoretic mobility. Extracts of
tumour tissue were found, by Caspary
and Field (1971), to produce similar effects
on sensitized lymphocytes. Similarly,
lymphocytes from Mantoux+ve indi-
viduals produced the macrophage slowing
factor (MSF) when incubated with PPD
antigen as by Carnegie et al. (1973).
Bert, di Cossano and Pecco (1969)
reported that the electrophoretic mobility
of lymphocytes from Mantoux+ve
patients could be reduced directly after
incubation with PPD. We have found
lymphocytes from both normal and dis-
eased individuals show reduced electro-
phoretic mobility when stimulated with
mitogens. This study attempts to deter-
mine the significance of the effect of EF
directly on the surface charge of sensi-
tized lymphocytes.
Lymphocytes.-Peripheral-blood lym-
phocytes were obtained from healthy
normal volunteers, patients with cancer
and 3 patients with benign tumours.
Blood was obtained from most of the
patients within 7 days after operation to
remove the tumour. All tumours were
diagnosed as malignant or benign histo-
logically. Heparinized blood was layered
over Ficoll-Hypaque (sp. gr. 1-078-1.079)
and centrifuged at 400 g for 30 min. The
cells at the interface were harvested and
washed with RPMI 1640 (Gibco, Grand
Island, New York). Such a preparation
gave a yield of about 90% mononuclear
cells. The final cell concentration was
adjusted with RPMI 1640 culture medium
to 0 5 x 106 cells/ml.
Preparation of EF.-EF was prepared
from human brain tissues obtained at
postmortem, according to the method of
Caspary and Field (1965, and 1971).
Lymphocyte Stimulation with Mitogen.
All lymphocyte cultures were in RPMI
1640 medium supplemented with 10%
inactivated human AB serum, 2 mm L-
glutamine (Gibco), 2.5% Hepes buffer
(Gibco), 100 u/ml of penicillin and 100
mEq/ml of streptomycin (both antibiotics
from Microbiological Assoc., Bethesda,
Maryland). Lymphocytes were incubated
with PHA (Difco, Detroit, Michigan) at
100 ,g/2 ml/106 lymphocytes in Falcon
plastic tubes. The cultures were incu-
bated at 37°C with 5% CO2. At 0,
21 1, 1t, 2 and 2k day intervals after
incubation, Falcon tubes from each indi-
vidual were harvested, and the lympho-
cytes were pooled and washed. They
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were then resuspended in normal saline
for measurements of EPM. Controls were
cultured without added PHA.
Lymphocyte Stimulation with EF.-
2-ml portions of lymphocyte suspension
were introduced into Falcon tubes as
before (106 cells/tube). Zero, 25 or 50 [kg
of EF were added to equal numbers of
tubes. They were incubated at 37°C with
5°O CO2 for 2 days. After incubation,
lymphocyte cultures with the same
amount of EF were pooled, washed and
resuspended for measurement of EPM.
C(ytophoresis (Mea83urement of EPM).
A Zeiss Cytophotometer (Carl Zeiss Inc.,
New York) was used for cytophoresis.
Detailed operations of the apparatus have
been described elsewhere (Hauss, Rothwell
and Straumfjord, 1964). The suspension
medium was a 0*85%o NaCl solution at
pH 7-4 with an ionic strength of 0-145.
The electric power source provides a
square-wave AC current of 5 mA at 0u05
Hz. A pair of Ag/AgCl electrodes was
used. The temperature of the chamber
was controlled at 25°0C.
The electrophoretic mobility of normal
lymphocytes was reduced after incubation
with PHA (Fig. 1). A maximum reduc-
tion in stimulated lymphocyte EPM was
6.4% relative to controls after 2 days
of incubation. Similar response to PHA
was observed for cancer patients' lym-
phocytes.
When cancer patients' Jymphocytes
were incubated with EF for 2 days, a dose
response curve was obtained (Fig. 2)
showing maximum reduction in EPM at a
concentration of 25 jUg/106 cells. This
dose-response curve represents a mean of
14 cancer patients investigated. The
mean dose-response curve of 10 normal
subjects and 3 benign-tumour patients is
also shown in Fig. 2. These give no
reduction in EPM after EF incubation.
The percentage change in EPM after
EF incubation at 25 jg/106 cells is shown
in Fig. 3. Percentage change is relative to
controls from the same sample incubated
without EF. For the 14 cancer patients
the change in EPM ranged from +0 87%
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FIG. 1. Changes in the average EPM of 5
normal subjects with time of incubation
with PHA (*) and no mitogens (0).
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FIG. 2. Tne mean EPM dose response to EF
in 10 normal subjects (0), 14 cancer
patients (-) and 3 benign-tumour patients
(A).
to -2-96% ( 1-33% mean) and for 10
normal persons the change in EPM ranged
from +2-24Oo to -1-58 (+0.24% mean).
The mean EPM change for the 3 benign-
tumour patients after EF incubation was
+0 72%. No relation to the type of
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FIG 3.-Percentagechanges inEPM innormal
subjects (A); cancer patients (B) and
benign-tumour patients (C) after their
lymphocytes had been incubated with EF
for 2 days. Horizontal bar indicates mean.
cancer was observed in EPM changes.
There was an overlap of about 50%
between the range of normals and the
range of cancer patients. Comparison
of the means of the cancer and normal
population demonstrate that cancer EPM
changes are significantly lower than that
of normals (0-02<P<0-025) when incu-
bated with 25pg/106 cells EF.
Field and Caspary had demonstrated
lymphocyte sensitization to EF in cancer
patients by detecting a product oftheir
activation, i.e., MSF. In our study, we
have shown that detectable changes also
occur in the lymphocyte cell-surface
charge of such patients after incubation
with EF. These changes are similar to
those demonstrated by Bert et al. (1969)
for lymphocyte sensitization in Mantoux-
+ve patients by incubation with PPD,
and by Rawlins, Wood and Bagshawe
(1976) who reported sensitization in
patients with malignant and nonmalignant
conditions as well as in normal controls,
to EF. We also found that lymphocyte
stimulation with PHA is accompanied by
reduction in EPM. Therefore a paral-
lelism could be drawn between these
phenomena in which stimulation of lym-
phocytes also result in a decreased EPM.
A significant difference was found in
mean EPM after EF incubation, between
normal lymphocytes and lymphocytes
from cancer patients (P<0 025). This
would imply an effect of EF directly on
the surface of lymphocytes which is
generally reflected in surface charge.
However, these changes are small and lead
to too much overlap between the cancer
and normal EPM for electrophoretic
measurement to be diagnostically applic-
able.
The work was supported by Research
and Development Funds, Department of
Pathology, The Medical College of Wis-
consin.
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